These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24922980)

  • 1. Current good manufacturing practices, quality control procedures, quality factors, notification requirements, and records and reports, for infant formula. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2014 Jun; 79(111):33057-72. PubMed ID: 24922980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment, maintenance, and availability of records: amendment to record availability requirements. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2014 Apr; 79(65):18799-802. PubMed ID: 24716304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Petition to request an exemption from 100 percent identity testing of dietary ingredients: Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements. Interim final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Jun; 72(121):34959-69. PubMed ID: 17674485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current good manufacturing practice in manufacturing, packaging, labeling, or holding operations for dietary supplements. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Jun; 72(121):34751-958. PubMed ID: 17674484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment, maintenance, and availability of records: amendment to record availability requirements. Interim final rule; request for comments.
    Food and Drug Administration, HHS
    Fed Regist; 2012 Feb; 77(36):10658-62. PubMed ID: 22379688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitigation Strategies To Protect Food Against Intentional Adulteration. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2016 May; 81(103):34165-223. PubMed ID: 27236872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and maintenance of records under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Dec; 69(236):71561-655. PubMed ID: 15586951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amendment to the current good manufacturing practice regulations for finished pharmaceuticals. Direct final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Dec; 72(232):68064-70. PubMed ID: 18064770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality control throughout the production process of infant food.
    Hamrin P; Hoeft B
    Ann Nutr Metab; 2012; 60(3):208-10. PubMed ID: 22699770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Registration of food facilities under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2005 Oct; 70(190):57505-9. PubMed ID: 16200686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of Salmonella enteritidis in shell eggs during production, storage, and transportation. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2009 Jul; 74(130):33029-101. PubMed ID: 19588581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A legal assessment of FDA's new HACCP regulations.
    McNamara SH
    Food Drug Law J; 1997; 52(1):39-47. PubMed ID: 10346708
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety standards in infant nutrition: a United States perspective.
    Bier DM
    Ann Nutr Metab; 2012; 60(3):192-5. PubMed ID: 22699766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UN strengthens regulations on melamine, seafood, melons, dried figs and labelling.
    Saudi Med J; 2012 Aug; 33(8):920-1. PubMed ID: 25291813
    [No Abstract]   [Full Text] [Related]  

  • 15. Toll-free number for reporting adverse events on labeling for human drug products. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Oct; 73(209):63886-97. PubMed ID: 19112682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infant formula record and record retention requirements--FDA. Final rule.
    Fed Regist; 1991 Dec; 56(247):66566-73. PubMed ID: 10116071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revisions to the requirements applicable to blood, blood components, and source plasma. Department of Health and Human Services (HHS), Public Health Service (PHS), Food and Drug Administration (FDA). Direct final rule.
    Fed Regist; 1999 Aug; 64(160):45366-74. PubMed ID: 10558597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sanitary Transportation of Human and Animal Food. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2016 Apr; 81(66):20091-170. PubMed ID: 27051895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical devices; exception from general requirements for informed consent. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2011 Jun; 76(122):36989-93. PubMed ID: 21736160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revision of requirements applicable to albumin (human), plasma protein fraction (human), and immune globulin (human). Food and Drug Administration, HHS. Direct final rule.
    Fed Regist; 1999 May; 64(93):26282-7. PubMed ID: 10558530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.